Review
doi: 10.1016/s0733-8635(05)70055-3.
Treatment of anogenital warts
Affiliations
- PMID: 9891689
- DOI: 10.1016/s0733-8635(05)70055-3
Item in Clipboard
Review
Treatment of anogenital warts
Dermatol Clin.
1998 Oct.
Abstract
The treatment of anogenital warts has long been unsatisfactory, with high treatment failure rates and relapse rates. It would seem that a good cell-mediated immune response is important for successful treatment, and the development of immune response modifiers such as Imiquimod give hope for an improved outcome for many patients.
Similar articles
-
New treatments for genital warts less than ideal: abstract and commentary.JAMA. 1998 Jun 24;279(24):2003-4. doi: 10.1001/jama.279.24.2003. JAMA. 1998. PMID: 9643868 No abstract available.
-
Imiquimod: an immune response modifier.J Am Acad Dermatol. 2000 Jul;43(1 Pt 2):S1-5. doi: 10.1067/mjd.2000.107809. J Am Acad Dermatol. 2000. PMID: 10861100 No abstract available.
-
Treatment of anogenital warts with imiquimod 5% cream followed by surgical excision of residual lesions.J Am Acad Dermatol. 2002 Oct;47(4 Suppl):S212-6. doi: 10.1067/mjd.2002.126579. J Am Acad Dermatol. 2002. PMID: 12271280 Review.
-
Therapeutic approaches to genital warts.Am J Med. 1997 May 5;102(5A):28-37. doi: 10.1016/s0002-9343(97)00181-2. Am J Med. 1997. PMID: 9217660 Review.
-
[Clinical aspects and therapy of anogenital warts and papillomavirus-associated lesions].Hautarzt. 2001 Jan;52(1):6-17. doi: 10.1007/s001050051254. Hautarzt. 2001. PMID: 11220242 Review. German.
Cited by
-
Complementary treatment with oral pidotimod plus vitamin C after laser vaporization for female genital warts: a prospective study.J Med Life. 2010 Jul-Sep;3(3):286-8. J Med Life. 2010. PMID: 20945819 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
